메뉴 건너뛰기




Volumn 172, Issue 7, 2015, Pages 1834-1845

AT-1001: A high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology

Author keywords

[No Author keywords available]

Indexed keywords

AT 1012; LARAZOTIDE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA3BETA4; NICOTINIC RECEPTOR ALPHA4BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; VARENICLINE; ALCOHOL; AT-1001; LIGAND; NICOTINE; NICOTINIC AGENT; OLIGOPEPTIDE;

EID: 84924931770     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13034     Document Type: Article
Times cited : (32)

References (47)
  • 3
    • 84865783996 scopus 로고    scopus 로고
    • The role of the habenula in nicotine addiction
    • pii: 002
    • Baldwin PR, Alanis R, Salas R, (2011). The role of the habenula in nicotine addiction. J Addict Res Ther S1: pii: 002.
    • (2011) J Addict Res Ther , vol.S1
    • Baldwin, P.R.1    Alanis, R.2    Salas, R.3
  • 4
    • 84924934879 scopus 로고    scopus 로고
    • AT-1001: Pharmacological profile at rat and human a3B4 and a4B2 nicotinic receptors
    • Poster # 224.26-Su
    • Bowman Dalley C, Lewin A, Tuan E, Al-Muhtasib N, Tran T, Gao Y, et al. (2013). AT-1001: pharmacological profile at rat and human a3B4 and a4B2 nicotinic receptors. Neuroscience 2013. Poster # 224.26-Su.
    • (2013) Neuroscience , vol.2013
    • Bowman Dalley, C.1    Lewin, A.2    Tuan, E.3    Al-Muhtasib, N.4    Tran, T.5    Gao, Y.6
  • 5
    • 78651407161 scopus 로고    scopus 로고
    • Partial agonists of the alpha3beta4∗ neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats
    • Chatterjee S, Steensland P, Simms JA, Holgate J, Coe JW, Hurst RS, et al. (2011). Partial agonists of the alpha3beta4∗ neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats. Neuropsychopharmacology 36: 603-615.
    • (2011) Neuropsychopharmacology , vol.36 , pp. 603-615
    • Chatterjee, S.1    Steensland, P.2    Simms, J.A.3    Holgate, J.4    Coe, J.W.5    Hurst, R.S.6
  • 6
    • 0015861774 scopus 로고
    • Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
    • Cheng Y, Prusoff WH, (1973). Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
    • (1973) Biochem Pharmacol , vol.22 , pp. 3099-3108
    • Cheng, Y.1    Prusoff, W.H.2
  • 7
    • 81255164797 scopus 로고    scopus 로고
    • Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats
    • Cippitelli A, Damadzic R, Singley E, Thorsell A, Ciccocioppo R, Eskay RL, et al. (2012). Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol Biochem Behav 100: 522-529.
    • (2012) Pharmacol Biochem Behav , vol.100 , pp. 522-529
    • Cippitelli, A.1    Damadzic, R.2    Singley, E.3    Thorsell, A.4    Ciccocioppo, R.5    Eskay, R.L.6
  • 8
    • 0033988388 scopus 로고    scopus 로고
    • Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice
    • Epping-Jordan MP, Picciotto MR, Changeux JP, Pich EM, (1999). Assessment of nicotinic acetylcholine receptor subunit contributions to nicotine self-administration in mutant mice. Psychopharmacology (Berl) 147: 25-26.
    • (1999) Psychopharmacology (Berl) , vol.147 , pp. 25-26
    • Epping-Jordan, M.P.1    Picciotto, M.R.2    Changeux, J.P.3    Pich, E.M.4
  • 9
    • 84891929233 scopus 로고    scopus 로고
    • Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial
    • Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, et al. (2014). Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial. JAMA 311: 145-154.
    • (2014) JAMA , vol.311 , pp. 145-154
    • Evins, A.E.1    Cather, C.2    Pratt, S.A.3    Pachas, G.N.4    Hoeppner, S.S.5    Goff, D.C.6
  • 10
    • 0344490327 scopus 로고    scopus 로고
    • Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function
    • Fitch RW, Xiao Y, Kellar KJ, Daly JW, (2003). Membrane potential fluorescence: a rapid and highly sensitive assay for nicotinic receptor channel function. Proc Natl Acad Sci U S A 100: 4909-4914.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 4909-4914
    • Fitch, R.W.1    Xiao, Y.2    Kellar, K.J.3    Daly, J.W.4
  • 12
    • 79953246461 scopus 로고    scopus 로고
    • Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake
    • Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ, (2011). Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471: 597-601.
    • (2011) Nature , vol.471 , pp. 597-601
    • Fowler, C.D.1    Lu, Q.2    Johnson, P.M.3    Marks, M.J.4    Kenny, P.J.5
  • 13
    • 79955658475 scopus 로고    scopus 로고
    • Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula
    • Frahm S, Slimak MA, Ferrarese L, Santos-Torres J, Antolin-Fontes B, Auer S, et al. (2011). Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula. Neuron 70: 522-535.
    • (2011) Neuron , vol.70 , pp. 522-535
    • Frahm, S.1    Slimak, M.A.2    Ferrarese, L.3    Santos-Torres, J.4    Antolin-Fontes, B.5    Auer, S.6
  • 14
    • 52249093734 scopus 로고    scopus 로고
    • Tobacco smoking cessation management: Integrating varenicline in current practice
    • Galanti LM, (2008). Tobacco smoking cessation management: integrating varenicline in current practice. Vasc Health Risk Manag 4: 837-845.
    • (2008) Vasc Health Risk Manag , vol.4 , pp. 837-845
    • Galanti, L.M.1
  • 15
    • 84856255709 scopus 로고    scopus 로고
    • Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking
    • Gamaleddin I, Zvonok A, Makriyannis A, Goldberg SR, Le Foll B, (2012). Effects of a selective cannabinoid CB2 agonist and antagonist on intravenous nicotine self administration and reinstatement of nicotine seeking. PLoS ONE 7: e29900.
    • (2012) PLoS ONE , vol.7 , pp. e29900
    • Gamaleddin, I.1    Zvonok, A.2    Makriyannis, A.3    Goldberg, S.R.4    Le Foll, B.5
  • 16
    • 79952485903 scopus 로고    scopus 로고
    • Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration
    • George O, Lloyd A, Carroll FI, Damaj MI, Koob GF, (2011). Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berl) 213: 715-722.
    • (2011) Psychopharmacology (Berl) , vol.213 , pp. 715-722
    • George, O.1    Lloyd, A.2    Carroll, F.I.3    Damaj, M.I.4    Koob, G.F.5
  • 18
    • 0033928656 scopus 로고    scopus 로고
    • Development of novel medications for drug addiction. The legacy of an African shrub
    • Glick SD, Maisonneuve IM, (2000). Development of novel medications for drug addiction. The legacy of an African shrub. Ann N Y Acad Sci 909: 88-103.
    • (2000) Ann N y Acad Sci , vol.909 , pp. 88-103
    • Glick, S.D.1    Maisonneuve, I.M.2
  • 19
    • 77951006621 scopus 로고    scopus 로고
    • Nicotinic acetylcholine receptors in the mesolimbic pathway: Primary role of ventral tegmental area alpha6beta2∗ receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement
    • Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M, et al. (2010). Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2∗ receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci 30: 5311-5325.
    • (2010) J Neurosci , vol.30 , pp. 5311-5325
    • Gotti, C.1    Guiducci, S.2    Tedesco, V.3    Corbioli, S.4    Zanetti, L.5    Moretti, M.6
  • 20
    • 84879463027 scopus 로고    scopus 로고
    • Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat
    • de Guglielmo G, Cippitelli A, Somaini L, Gerra G, Li H, Stopponi S, et al. (2013). Pregabalin reduces cocaine self-administration and relapse to cocaine seeking in the rat. Addict Biol 18: 644-653.
    • (2013) Addict Biol , vol.18 , pp. 644-653
    • De Guglielmo, G.1    Cippitelli, A.2    Somaini, L.3    Gerra, G.4    Li, H.5    Stopponi, S.6
  • 21
    • 33745611449 scopus 로고    scopus 로고
    • Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial
    • Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296: 56-63.
    • (2006) JAMA , vol.296 , pp. 56-63
    • Jorenby, D.E.1    Hays, J.T.2    Rigotti, N.A.3    Azoulay, S.4    Watsky, E.J.5    Williams, K.E.6
  • 22
    • 0021808471 scopus 로고
    • The quantification of relative efficacy of agonists
    • Kenakin TP, (1985). The quantification of relative efficacy of agonists. J Pharmacol Methods 13: 281-308.
    • (1985) J Pharmacol Methods , vol.13 , pp. 281-308
    • Kenakin, T.P.1
  • 23
    • 84862860563 scopus 로고    scopus 로고
    • Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage
    • Khroyan TV, Zhang J, Yang L, Zou B, Xie J, Pascual C, et al. (2012). Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage. Clin Exp Pharmacol Physiol 39: 614-622.
    • (2012) Clin Exp Pharmacol Physiol , vol.39 , pp. 614-622
    • Khroyan, T.V.1    Zhang, J.2    Yang, L.3    Zou, B.4    Xie, J.5    Pascual, C.6
  • 26
    • 84871526073 scopus 로고    scopus 로고
    • Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used
    • Le Foll B, Chakraborty-Chatterjee M, Lev-Ran S, Barnes C, Pushparaj A, Gamaleddin I, et al. (2012). Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used. Int J Neuropsychopharmacol 15: 1265-1274.
    • (2012) Int J Neuropsychopharmacol , vol.15 , pp. 1265-1274
    • Le Foll, B.1    Chakraborty-Chatterjee, M.2    Lev-Ran, S.3    Barnes, C.4    Pushparaj, A.5    Gamaleddin, I.6
  • 27
    • 77249132728 scopus 로고    scopus 로고
    • Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats
    • Levin ED, Rezvani AH, Xiao Y, Slade S, Cauley M, Wells C, et al. (2010). Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. J Pharmacol Exp Ther 332: 933-939.
    • (2010) J Pharmacol Exp Ther , vol.332 , pp. 933-939
    • Levin, E.D.1    Rezvani, A.H.2    Xiao, Y.3    Slade, S.4    Cauley, M.5    Wells, C.6
  • 28
    • 0043199750 scopus 로고    scopus 로고
    • Anti-addictive actions of an iboga alkaloid congener: A novel mechanism for a novel treatment
    • Maisonneuve IM, Glick SD, (2003). Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment. Pharmacol Biochem Behav 75: 607-618.
    • (2003) Pharmacol Biochem Behav , vol.75 , pp. 607-618
    • Maisonneuve, I.M.1    Glick, S.D.2
  • 29
    • 0036312108 scopus 로고    scopus 로고
    • Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice
    • Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC, (2002). Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. J Neurochem 81: 1102-1115.
    • (2002) J Neurochem , vol.81 , pp. 1102-1115
    • Marks, M.J.1    Whiteaker, P.2    Grady, S.R.3    Picciotto, M.R.4    McIntosh, J.M.5    Collins, A.C.6
  • 30
    • 77954331629 scopus 로고    scopus 로고
    • Guidelines for reporting experiments involving animals: The ARRIVE guidelines
    • McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
    • (2010) Br J Pharmacol , vol.160 , pp. 1573-1576
    • McGrath, J.1    Drummond, G.2    McLachlan, E.3    Kilkenny, C.4    Wainwright, C.5
  • 31
    • 33747598710 scopus 로고    scopus 로고
    • Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors
    • Mihalak KB, Carroll FI, Luetje CW, (2006). Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70: 801-805.
    • (2006) Mol Pharmacol , vol.70 , pp. 801-805
    • Mihalak, K.B.1    Carroll, F.I.2    Luetje, C.W.3
  • 32
    • 77649238532 scopus 로고    scopus 로고
    • The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats
    • O'Connor EC, Parker D, Rollema H, Mead AN, (2010). The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats. Psychopharmacology (Berl) 208: 365-376.
    • (2010) Psychopharmacology (Berl) , vol.208 , pp. 365-376
    • O'Connor, E.C.1    Parker, D.2    Rollema, H.3    Mead, A.N.4
  • 34
    • 84891791940 scopus 로고    scopus 로고
    • The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
    • NC-IUPHAR
    • Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-1106.
    • (2014) Nucl. Acids Res. , vol.42 , Issue.DATABASE ISSUE , pp. D1098-D1106
    • Pawson, A.J.1    Sharman, J.L.2    Benson, H.E.3    Faccenda, E.4    Alexander, S.P.5    Buneman, O.P.6
  • 35
    • 0036325126 scopus 로고    scopus 로고
    • Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography
    • Perry DC, Xiao Y, Nguyen HN, Musachio JL, Davila-Garcia MI, Kellar KJ, (2002). Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography. J Neurochem 82: 468-481.
    • (2002) J Neurochem , vol.82 , pp. 468-481
    • Perry, D.C.1    Xiao, Y.2    Nguyen, H.N.3    Musachio, J.L.4    Davila-Garcia, M.I.5    Kellar, K.J.6
  • 36
    • 34250771613 scopus 로고    scopus 로고
    • Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain
    • Perry DC, Mao D, Gold AB, McIntosh JM, Pezzullo JC, Kellar KJ, (2007). Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 322: 306-315.
    • (2007) J Pharmacol Exp Ther , vol.322 , pp. 306-315
    • Perry, D.C.1    Mao, D.2    Gold, A.B.3    McIntosh, J.M.4    Pezzullo, J.C.5    Kellar, K.J.6
  • 37
    • 0032495515 scopus 로고    scopus 로고
    • Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine
    • Picciotto MR, Zoli M, Rimondini R, Lena C, Marubio LM, Pich EM, et al. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
    • (1998) Nature , vol.391 , pp. 173-177
    • Picciotto, M.R.1    Zoli, M.2    Rimondini, R.3    Lena, C.4    Marubio, L.M.5    Pich, E.M.6
  • 38
    • 58149385076 scopus 로고    scopus 로고
    • Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration
    • Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, et al. (2008). Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. J Neurosci 28: 12318-12327.
    • (2008) J Neurosci , vol.28 , pp. 12318-12327
    • Pons, S.1    Fattore, L.2    Cossu, G.3    Tolu, S.4    Porcu, E.5    McIntosh, J.M.6
  • 39
    • 0029980944 scopus 로고    scopus 로고
    • Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy
    • Richardson NR, Roberts DC, (1996). Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66: 1-11.
    • (1996) J Neurosci Methods , vol.66 , pp. 1-11
    • Richardson, N.R.1    Roberts, D.C.2
  • 40
    • 33846858426 scopus 로고    scopus 로고
    • Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid
    • Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, et al. (2007). Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52: 985-994.
    • (2007) Neuropharmacology , vol.52 , pp. 985-994
    • Rollema, H.1    Chambers, L.K.2    Coe, J.W.3    Glowa, J.4    Hurst, R.S.5    Lebel, L.A.6
  • 41
    • 34547630911 scopus 로고    scopus 로고
    • Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
    • Steensland P, Simms JA, Holgate J, Richards JK, Bartlett SE, (2007). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci U S A 104: 12518-12523.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 12518-12523
    • Steensland, P.1    Simms, J.A.2    Holgate, J.3    Richards, J.K.4    Bartlett, S.E.5
  • 42
    • 8344245466 scopus 로고    scopus 로고
    • Nicotine activation of alpha4∗ receptors: Sufficient for reward, tolerance, and sensitization
    • Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et al. (2004). Nicotine activation of alpha4∗ receptors: sufficient for reward, tolerance, and sensitization. Science 306: 1029-1032.
    • (2004) Science , vol.306 , pp. 1029-1032
    • Tapper, A.R.1    McKinney, S.L.2    Nashmi, R.3    Schwarz, J.4    Deshpande, P.5    Labarca, C.6
  • 43
    • 84859742106 scopus 로고    scopus 로고
    • AT-1001: A high affinity and selective alpha3beta4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats
    • Toll L, Zaveri NT, Polgar WE, Jiang F, Khroyan TV, Zhou W, et al. (2012). AT-1001: a high affinity and selective alpha3beta4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology 37: 1367-1376.
    • (2012) Neuropsychopharmacology , vol.37 , pp. 1367-1376
    • Toll, L.1    Zaveri, N.T.2    Polgar, W.E.3    Jiang, F.4    Khroyan, T.V.5    Zhou, W.6
  • 44
    • 84872003960 scopus 로고    scopus 로고
    • Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity
    • Vazquez-DeRose J, Stauber G, Khroyan TV, Xie XS, Zaveri NT, Toll L, (2013). Retrodialysis of N/OFQ into the nucleus accumbens shell blocks cocaine-induced increases in extracellular dopamine and locomotor activity. Eur J Pharmacol 699: 200-206.
    • (2013) Eur J Pharmacol , vol.699 , pp. 200-206
    • Vazquez-Derose, J.1    Stauber, G.2    Khroyan, T.V.3    Xie, X.S.4    Zaveri, N.T.5    Toll, L.6
  • 46
    • 84886259723 scopus 로고    scopus 로고
    • 1)(2)(5)I]AT-1012, a new high affinity radioligand for the alpha3beta4 nicotinic acetylcholine receptors
    • Wu J, Perry DC, Bupp JE, Jiang F, Polgar WE, Toll L, et al. (2014). 1)(2)(5)I]AT-1012, a new high affinity radioligand for the alpha3beta4 nicotinic acetylcholine receptors. Neuropharmacology 77: 193-199.
    • (2014) Neuropharmacology , vol.77 , pp. 193-199
    • Wu, J.1    Perry, D.C.2    Bupp, J.E.3    Jiang, F.4    Polgar, W.E.5    Toll, L.6
  • 47
    • 84924937479 scopus 로고    scopus 로고
    • Functional characterization of AT-1001, an alpha3beta4 nicotinic acetylcholine receptor (nAChR) ligand, at human alpha3beta4 and alpha4beta2 nAChR
    • pii: ntu170. [Epub ahead of print]
    • Zaveri NT, Bertrand S, Yasuda D, Bertrand D, (2014). Functional characterization of AT-1001, an alpha3beta4 nicotinic acetylcholine receptor (nAChR) ligand, at human alpha3beta4 and alpha4beta2 nAChR. Nicotine Tob Res pii: ntu170. [Epub ahead of print].
    • (2014) Nicotine Tob Res
    • Zaveri, N.T.1    Bertrand, S.2    Yasuda, D.3    Bertrand, D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.